LR Metsch, DJ Feaster, LK Gooden… - Open forum …, 2021 - academic.oup.com
Background Direct-acting antivirals can cure hepatitis C virus (HCV). Persons with HCV/HIV and living with substance use are disadvantaged in benefiting from advances in HCV …
D Zarębska-Michaluk, J Jaroszewicz… - Journal of Clinical …, 2022 - mdpi.com
The introduction of the direct-acting antivirals (DAA) has substantially improved the effectiveness of the therapy in patients with chronic hepatitis C. We aimed to compare the …
J Yin, L Hill, M Mansour, S Collier… - British Journal of …, 2023 - Wiley Online Library
Co‐administration of hepatitis C virus (HCV) direct‐acting antivirals (DAAs) with anti‐ epileptics or mood stabilizers with cytochrome P450 (CYP) and/or drug transport‐inducing …
M Takatsuki, K Natsuda, M Hidaka… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection through unheated blood product for hemophilia caused in early 1980s has been significantly …
JA Collins Camones, ER Chamorro Chirinos… - Revista de …, 2022 - scielo.org.pe
Resumen COLLINS CAMONES, Jaime Antonio; CHAMORRO CHIRINOS, Elena Rocío y LOYOLA SALVATIERRA, Fiorella Vanessa. Primer reporte en Perú sobre terapia con …
The development of drug resistant mutations in bacterial and viral pathogens is an emerging threat to global public health. The rampant propagation of drug resistant pathogens has …
Effective management of HIV and hepatitis C virus (HCV) coinfection warrants special emphasis on interactions between direct acting antivirals (DAAs) and antiretroviral therapy …
Advances in antiretroviral therapy have led to drastic improvements in survival among people living with HIV. However, as life expectancies have increased, so too has the …